Valuation Cuorips Inc.

Stocks

Market Closed - Japan Exchange 09:30:00 28/09/2026 +03			5-day change	1st Jan Change
5,730.00 ^JPY	-3.37%		-1.55%	-4.98%

09-11	Cuorips Inc. announced that it expects to receive ¥2.9999677 billion in funding from JIC Venture Growth Investments Co., Ltd.	CI
02-20	Japan Panel Clears First iPS Cell Therapies for Conditional Sale	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2024	2025	2026
Market Cap ¹	29,126	67,173	57,885
Change	-	130.63%	-13.83%
Enterprise Value (EV) ¹	23,544	62,380	53,986
Change	-	164.96%	-13.46%
P/E	-43x	-103x	-56.3x
PBR	4.91x	12.2x	12.2x
PEG	-	16.48x	-1x
Capitalization / Revenue	1,266x	384x	273x
EV / Revenue	1,024x	356x	255x
EV / EBITDA	-45.5x	-121x	-54.1x
EV / EBIT	-40x	-106x	-49.9x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-85.84	-80.48	-124.5
Distribution rate	-	-	-
Net sales ¹	23	175	212
EBITDA ¹	-518	-514	-997
EBIT ¹	-588	-590	-1,081
Net income ¹	-632	-644	-1,022
Net Debt ¹	-5,582	-4,793	-3,899
Reference price ²	3,695.00	8,310.00	7,010.00
Nbr of stocks (in thousands)	7,882	8,083	8,258
Announcement Date	6/27/24 A	6/20/25 A	6/24/26 A

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CUORIPS INC.	-	-	-	-	311M
MODERNA, INC.	-23.72x	36.06x	-23.41x	-.--%	79.4B
REGENERON PHARMACEUTICALS, INC.	17.96x	4.21x	9.93x	0.5%	78.69B
CSL LIMITED	20.46x	4.36x	13.5x	2.42%	59.52B
UCB	21.44x	4.75x	13.52x	0.68%	46.58B
SAMSUNG BIOLOGICS CO.,LTD.	33.28x	11.32x	21.7x	-.--%	46.53B
BIOGEN INC.	37.12x	3.69x	13.85x	-.--%	33.63B
INCYTE CORPORATION	55.29x	3.51x	27.23x	-.--%	25.11B
INNOVENT BIOLOGICS, INC.	63.28x	7.06x	42.21x	-.--%	22.13B
SWEDISH ORPHAN BIOVITRUM AB	22.86x	4.91x	12.8x	-.--%	15.31B
Average	27.55x	8.88x	14.59x	0.4%	40.72B
Weighted average by Cap.	18.88x	11.42x	8.96x	0.53%